跳至主要内容
临床试验/JPRN-UMIN000019798
JPRN-UMIN000019798已完成2 期

A study on the efficacy and safety of chemotherapy with paclitaxel, ifosfamide, cisplatin for metastatic penile cancer - A study on the efficacy and safety of chemotherapy with paclitaxel, ifosfamide, cisplatin for metastatic penile cancer

Tohoku university hospital, Department of Urology0 个研究点目标入组 10 人开始时间: 2015年11月17日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 85years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1. Patients with pulmonary fibrosis or interstitial pneumonia, who diagnosed by chest X-ray and clinical symptoms. 2.Patients with NYHA Class III or IV heart failure and/or patients who have a history of myocardial infarction within 6 months. 3. Patients with severe infection. 4.Patients with severe comorbidity (include uncontrolled diabetes mellitus in spite of insulin therapy). 5. Patients with severe drug allergy. 6.Patients with multiple active primary cancers. 7.Patients who wish to partner pregnancy in course of chemotherapy or within 6 months from the final chemotherapy. 8.Patients who are not suitable for chemotherapy with any reason are excluded by physician's judgment.

研究者

发起方
Tohoku university hospital, Department of Urology

相似试验